278 related articles for article (PubMed ID: 26134824)
1. TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer.
Grimmig T; Matthes N; Hoeland K; Tripathi S; Chandraker A; Grimm M; Moench R; Moll EM; Friess H; Tsaur I; Blaheta RA; Germer CT; Waaga-Gasser AM; Gasser M
Int J Oncol; 2015 Sep; 47(3):857-66. PubMed ID: 26134824
[TBL] [Abstract][Full Text] [Related]
2. Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.
Cherfils-Vicini J; Platonova S; Gillard M; Laurans L; Validire P; Caliandro R; Magdeleinat P; Mami-Chouaib F; Dieu-Nosjean MC; Fridman WH; Damotte D; Sautès-Fridman C; Cremer I
J Clin Invest; 2010 Apr; 120(4):1285-97. PubMed ID: 20237413
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptors 7, 8, and 9 expression and function in primary human cervical cancer Langerhans cells: evidence of anergy.
Kumar MM; Adurthi S; Ramachandran S; Mukherjee G; Joy O; Krishnamurthy H; Krishna S; Bafna UD; Uma DK; Jayshree RS
Int J Gynecol Cancer; 2013 Jan; 23(1):184-92. PubMed ID: 23221735
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor (TLR) 7 and TLR8 expression on CD133+ cells in colorectal cancer points to a specific role for inflammation-induced TLRs in tumourigenesis and tumour progression.
Grimm M; Kim M; Rosenwald A; Heemann U; Germer CT; Waaga-Gasser AM; Gasser M
Eur J Cancer; 2010 Oct; 46(15):2849-57. PubMed ID: 20728343
[TBL] [Abstract][Full Text] [Related]
5. Cancer immunotherapeutic potential of novel small molecule TLR7 and TLR8 agonists.
Hamm S; Rath S; Michel S; Baumgartner R
J Immunotoxicol; 2009 Dec; 6(4):257-65. PubMed ID: 19848448
[TBL] [Abstract][Full Text] [Related]
6. The TLR7/8 ligand resiquimod targets monocyte-derived dendritic cell differentiation via TLR8 and augments functional dendritic cell generation.
Hackstein H; Knoche A; Nockher A; Poeling J; Kubin T; Jurk M; Vollmer J; Bein G
Cell Immunol; 2011; 271(2):401-12. PubMed ID: 21889130
[TBL] [Abstract][Full Text] [Related]
7. Functional polymorphisms of the TLR7 and TLR8 genes contribute to Mycobacterium tuberculosis infection.
Lai YF; Lin TM; Wang CH; Su PY; Wu JT; Lin MC; Eng HL
Tuberculosis (Edinb); 2016 May; 98():125-31. PubMed ID: 27156628
[TBL] [Abstract][Full Text] [Related]
8. TLR7 and TLR8 Differentially Activate the IRF and NF-κB Pathways in Specific Cell Types to Promote Inflammation.
Bender AT; Tzvetkov E; Pereira A; Wu Y; Kasar S; Przetak MM; Vlach J; Niewold TB; Jensen MA; Okitsu SL
Immunohorizons; 2020 Feb; 4(2):93-107. PubMed ID: 32086319
[TBL] [Abstract][Full Text] [Related]
9. Molecular characterization and expression analysis of TLR 7 and TLR 8 homologs in large yellow croaker (Pseudosciaena crocea).
Qian T; Wang K; Mu Y; Ao J; Chen X
Fish Shellfish Immunol; 2013 Sep; 35(3):671-9. PubMed ID: 23742866
[TBL] [Abstract][Full Text] [Related]
10. Stabilized immune modulatory RNA compounds as agonists of Toll-like receptors 7 and 8.
Lan T; Kandimalla ER; Yu D; Bhagat L; Li Y; Wang D; Zhu F; Tang JX; Putta MR; Cong Y; Trombino AF; Sullivan T; Agrawal S
Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13750-5. PubMed ID: 17698957
[TBL] [Abstract][Full Text] [Related]
11. Endosomal TLR3, TLR7, and TLR8 control neuronal morphology through different transcriptional programs.
Hung YF; Chen CY; Shih YC; Liu HY; Huang CM; Hsueh YP
J Cell Biol; 2018 Aug; 217(8):2727-2742. PubMed ID: 29777026
[TBL] [Abstract][Full Text] [Related]
12. TLR7 and TLR8 ligands and antiphospholipid antibodies show synergistic effects on the induction of IL-1beta and caspase-1 in monocytes and dendritic cells.
Hurst J; Prinz N; Lorenz M; Bauer S; Chapman J; Lackner KJ; von Landenberg P
Immunobiology; 2009; 214(8):683-91. PubMed ID: 19249118
[TBL] [Abstract][Full Text] [Related]
13. Modulating responsiveness of human TLR7 and 8 to small molecule ligands with T-rich phosphorothiate oligodeoxynucleotides.
Jurk M; Kritzler A; Schulte B; Tluk S; Schetter C; Krieg AM; Vollmer J
Eur J Immunol; 2006 Jul; 36(7):1815-26. PubMed ID: 16783850
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
[TBL] [Abstract][Full Text] [Related]
15. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9.
Wang J; Shao Y; Bennett TA; Shankar RA; Wightman PD; Reddy LG
J Biol Chem; 2006 Dec; 281(49):37427-34. PubMed ID: 17040905
[TBL] [Abstract][Full Text] [Related]
16. Activation of Toll-like receptor 7 inhibits the proliferation and migration, and induces the apoptosis of pancreatic cancer cells.
Zou BB; Wang F; Li L; Cheng FW; Jin R; Luo X; Zhu LX; Geng X; Zhang SQ
Mol Med Rep; 2015 Oct; 12(4):6079-85. PubMed ID: 26238718
[TBL] [Abstract][Full Text] [Related]
17. TLR7 Ligation Inhibits TLR8 Responsiveness in IL-27-Primed Human THP-1 Monocytes and Macrophages.
Odoardi N; Kourko O; Petes C; Basta S; Gee K
J Innate Immun; 2021; 13(6):345-358. PubMed ID: 34058746
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 7 regulates pancreatic carcinogenesis in mice and humans.
Ochi A; Graffeo CS; Zambirinis CP; Rehman A; Hackman M; Fallon N; Barilla RM; Henning JR; Jamal M; Rao R; Greco S; Deutsch M; Medina-Zea MV; Bin Saeed U; Ego-Osuala MO; Hajdu C; Miller G
J Clin Invest; 2012 Nov; 122(11):4118-29. PubMed ID: 23023703
[TBL] [Abstract][Full Text] [Related]
19. TLR7 and TLR8 gene variations and susceptibility to hepatitis C virus infection.
Wang CH; Eng HL; Lin KH; Chang CH; Hsieh CA; Lin YL; Lin TM
PLoS One; 2011; 6(10):e26235. PubMed ID: 22022576
[TBL] [Abstract][Full Text] [Related]
20. Selective and direct activation of human neutrophils but not eosinophils by Toll-like receptor 8.
Janke M; Poth J; Wimmenauer V; Giese T; Coch C; Barchet W; Schlee M; Hartmann G
J Allergy Clin Immunol; 2009 May; 123(5):1026-33. PubMed ID: 19361845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
